Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Usher syndrome is the most common condition that affects both hearing and vision; sometimes it also affects balance. The major symptoms of Usher syndrome are deafness or hearing loss and an eye disease called retinitis pigmentosa (RP). Deafness or hearing…

Modern cataract surgery is generally a successful procedure. Recent advancements—which involve the use of pre- and intraoperative pharmacological protocols combined with optimal instrumentation allow for well-tolerated and effective procedures in the vast majority of patients. The maintenance of mydriasis and…

Staring at Red Light for 3 Minutes Appears to Improve Eyesight in Over 40s. Scientists believe shining a special red light in the eye could help improve age-related vision problems. The age spectrum of human populations is shifting towards the…

Dry eye disease includes a group of conditions in which the eye does not produce an adequate volume of tears or when the tears are not of the correct consistency. The chance of experiencing dry eye increases with age, affecting approximately…

Dry eye is related to the inflammation of ocular surface, and immune-mediated inflammation plays an important pathogenic role. Corticosteroid is an effective anti-inflammatory drug, which can rapidly and effectively relieve the symptoms and signs of moderate or severe dry eye.…

Inherited retinal diseases (IRDs), also referred to as inherited retinal dystrophies, are a clinically and genetically heterogeneous group of neurodegenerative disorders, primarily involving photoreceptors, retinal pigment epithelium (RPE), and/or the choroid. Taken as a whole, IRDs have an estimated global…

ESCRS Board Member Prof.Dr. Ewa Mrukwa-Kominek told that Acriva Trinova implanted patients do not experience glare and halos and have very sharp visual equity. Halos are bright circles that surround a light source, like headlights. Glare is light that enters…

TelomEYE Pharmaceuticals Corporation, working on a new generation of ophthalmologic therapies, announced today the completion of a successful $1 million post-seed funding round, valuing the company at $10 million USD. The round was co-led by healthcare mogul Mehmet Ali Aydınlar,…

Sight Sciences has launched the Ergo-Series of the OMNI Surgical System in the US, which is specifically designed to help surgeons in performing minimally invasive, implant-free glaucoma procedures in adults suffering from primary open-angle glaucoma. The OMNI Surgical System facilitates…

Selagine announced a global collaboration with Grifols to develop and commercialize immunoglobulin eye drops for dry eye disease. Financial terms of the agreement were not disclosed. As per the agreement, Selagine will receive an upfront payment and annual collaboration fee,…